Search Page

1

Cite

Share

Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective.

Alsumali A, Djatche LM, Briggs A, Liu R, Diakite I, Patel D, Wang Y, Lautsch D. Alsumali A, et al. Among authors: lautsch d. Pharmacoeconomics. 2021 Nov;39(11):1343-1354. doi: 10.1007/s40273-021-01091-w. Epub 2021 Oct 8. Pharmacoeconomics. 2021. PMID: 34623625 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

How does the TRS 2°P score relate to real-world patients?

Bonaca MP, De Ferrari GM, Atar D, Bash LD, Lautsch D, Bohula EA, Horack M, Brudi P, Ferrieres J, Gitt AK. Bonaca MP, et al. Among authors: lautsch d. Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):72-74. doi: 10.1093/ehjcvp/pvy004. Eur Heart J Cardiovasc Pharmacother. 2018. PMID: 29554293 Free PMC article. No abstract available.

Cite

Share

3

Cite

Share

Early diagnosis of acute coronary syndrome.

Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S, Blankenberg S, Brueckmann M, Collinson P, Comaniciu D, Crea F, Dinh W, Ducrocq G, Flachskampf FA, Fox KAA, Friedrich MG, Hebert KA, Himmelmann A, Hlatky M, Lautsch D, Lindahl B, Lindholm D, Mills NL, Minotti G, Möckel M, Omland T, Semjonow V. Katus H, et al. Among authors: lautsch d. Eur Heart J. 2017 Nov 1;38(41):3049-3055. doi: 10.1093/eurheartj/ehx492. Eur Heart J. 2017. PMID: 29029109

Cite

Share

4

Cite

Share

New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk.

Graham I, Shear C, De Graeff P, Boulton C, Catapano AL, Stough WG, Carlsson SC, De Backer G, Emmerich J, Greenfeder S, Kim AM, Lautsch D, Nguyen T, Nissen SE, Prasad K, Ray KK, Robinson JG, Sasiela WJ, Bruins Slot K, Stroes E, Thuren T, Van der Schueren B, Velkovski-Rouyer M, Wasserman SM, Wiklund O, Zouridakis E; European Society of Cardiology Cardiovascular Roundtable. Graham I, et al. Among authors: lautsch d. Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):119-127. doi: 10.1093/ehjcvp/pvx031. Eur Heart J Cardiovasc Pharmacother. 2018. PMID: 29194462 Review.

Cite

Share

5

Cite

Share

Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis.

Dunbar SB, Tan X, Lautsch D, Yang M, Ricker B, Maculaitis MC, Nagle T, Clark LT, Hilkert R, Brady JE, Spertus JA. Dunbar SB, et al. Among authors: lautsch d. J Card Fail. 2021 Aug;27(8):877-887. doi: 10.1016/j.cardfail.2021.05.017. J Card Fail. 2021. PMID: 34364664 Free article.

Cite

Share

6

Cite

Share

Two steps forward, one step back: 50 years of societal value from LDL-C-lowering therapies.

MacEwan JP, Zhao LM, Everson K, Liu L, Lautsch D, Sun F, Lakdawalla DN. MacEwan JP, et al. Among authors: lautsch d. Am J Manag Care. 2021 Apr;27(4):162-168. doi: 10.37765/ajmc.2021.88618. Am J Manag Care. 2021. PMID: 33877775 Free article.

Cite

Share

7

Cite

Share

Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry.

Butler J, Djatche LM, Lautsch D, Yang L, Patel MJ, Mentz RJ. Butler J, et al. Among authors: lautsch d. J Card Fail. 2021 Dec;27(12):1374-1381. doi: 10.1016/j.cardfail.2021.06.019. Epub 2021 Jul 13. J Card Fail. 2021. PMID: 34271161

Cite

Share

8

Cite

Share

Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction.

Mentz RJ, Lautsch D, Pulungan Z, Kim S, Hilkert R, Teigland C, Yang M, Djatche L. Mentz RJ, et al. Among authors: lautsch d. J Card Fail. 2021 Dec 17:S1071-9164(21)00475-9. doi: 10.1016/j.cardfail.2021.11.013. Online ahead of print. J Card Fail. 2021. PMID: 34930657

Cite

Share

9

Cite

Share

Hemoglobin A1C testing frequency among patients with type 2 diabetes within a US payer system: a retrospective observational study.

Weiss T, Edwards A, Lautsch D, Rajpathak S, Snow K. Weiss T, et al. Among authors: lautsch d. Curr Med Res Opin. 2021 Nov;37(11):1859-1866. doi: 10.1080/03007995.2021.1965562. Epub 2021 Aug 26. Curr Med Res Opin. 2021. PMID: 34402701

Cite

Share

10

Cite

Share

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event.

Alsumali A, Lautsch D, Liu R, Patel D, Nanji S, Djatche LM. Alsumali A, et al. Among authors: lautsch d. Adv Ther. 2021 May;38(5):2631-2643. doi: 10.1007/s12325-021-01681-2. Epub 2021 Apr 16. Adv Ther. 2021. PMID: 33860924 Free PMC article. Clinical Trial.

Cite

Share